Arcutis Biotherapeutics (ARQT) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Sep 2025 value amounting to $0.06.
- Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) rose 118.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 78.92%. This contributed to the annual value of -$1.16 for FY2024, which is 69.31% up from last year.
- As of Q3 2025, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) stood at $0.06, which was up 146.15% from -$0.13 recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q3 2025 and a low of -$1.89 during Q3 2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.33 (2024), whereas its average is -$0.47.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 67.11% in 2022, then spiked by 118.18% in 2025.
- Arcutis Biotherapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.43 in 2021, then climbed by 20.28% to -$1.14 in 2022, then spiked by 48.25% to -$0.59 in 2023, then spiked by 86.44% to -$0.08 in 2024, then soared by 118.18% to $0.06 in 2025.
- Its last three reported values are $0.06 in Q3 2025, -$0.13 for Q2 2025, and -$0.20 during Q1 2025.